GO:0002001 renin secretion into blood stream: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002001 (renin secretion into blood stream) is the regulated release of renin into the bloodstream by juxtaglomerular cells.
• Renin is the rate-limiting enzyme of the renin-angiotensin system (RAS), and its secretion controls angiotensin II generation and blood pressure.
• The intrarenal RAS is compartmentalized, with renin, angiotensinogen, ACE and angiotensins localized in specific kidney structures.
• Sympathetic beta-adrenergic stimulation and cAMP signaling can drive renin secretion and local RAS activity.
• Perivascular adipose tissue can locally synthesize angiotensinogen and modulate vascular RAS, influencing renin secretion indirectly.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect the genetic control of renin secretion.
Description
Renin secretion into blood stream (GO:0002001) is the regulated release of renin into the bloodstream by juxtaglomerular cells. This process is the first and rate-limiting step of the renin-angiotensin system (RAS), a hormonal cascade that governs blood pressure, fluid balance and vascular tone. Because renin secretion determines the systemic availability of angiotensin II, it is a central node in cardiovascular physiology and a major target for antihypertensive therapy. The intrarenal RAS is not a simple endocrine loop; immunocytochemical studies have shown that renin, angiotensinogen, converting enzyme and angiotensins are localized in distinct kidney compartments, indicating that renin secretion is spatially and temporally regulated. Dysregulation of renin secretion contributes to congestive heart failure, hypertension and renal fibrosis, making it a high-value area for mechanistic and translational research. Understanding the molecular control of renin secretion requires integrating neuroendocrine, paracrine and intracellular signaling inputs.
renin secretion into blood stream At A Glance
| GO ID | GO:0002001 |
|---|---|
| GO term | renin secretion into blood stream |
| Ontology | biological_process |
| Synonym | renin release into blood stream |
| Major function | Regulated release of renin from juxtaglomerular cells into the bloodstream, initiating the renin-angiotensin system |
| Cellular source | Juxtaglomerular cells of the kidney |
| Physiological role | Controls angiotensin II production, blood pressure and fluid homeostasis |
| Regulatory input | Sympathetic beta-adrenergic stimulation and cAMP signaling |
| Related tissue | Perivascular adipose tissue can locally modulate RAS and influence renin secretion |
What Is GO:0002001?
According to the Gene Ontology, GO:0002001 (renin secretion into blood stream) is defined as the regulated release of renin into the blood stream by juxtaglomerular cells. The synonym renin release into blood stream is also used. This is a biological process that specifically refers to the secretion of active renin from renal juxtaglomerular cells into the circulation, rather than to renin synthesis or intracellular processing alone.
Why Is renin secretion into blood stream Important in Cell Biology?
Renin secretion into blood stream is important because it is the rate-limiting step of the RAS and directly determines circulating angiotensin II levels, which regulate blood pressure, sodium retention and vascular remodeling. Experimental and clinical evidence links altered renin secretion to congestive cardiac failure, hypertension and renal fibrosis. Moreover, local RAS activity in tissues such as the eye and perivascular adipose tissue can be influenced by systemic sympathetic tone, expanding the relevance of renin secretion beyond the kidney.
• Rate-limiting step of the renin-angiotensin system and a key determinant of blood pressure.
• Controls angiotensin II generation, which drives vasoconstriction and aldosterone release.
• Dysregulated renin secretion is implicated in congestive heart failure and hypertension.
• Renal fibrosis and inflammation can be modulated by RAS activity downstream of renin secretion.
• Sympathetic beta-adrenergic stimulation and cAMP signaling regulate renin secretion and local RAS.
• Perivascular adipose tissue can locally synthesize angiotensinogen and influence vascular RAS.
• Intrarenal RAS components are compartmentalized, indicating tight spatial control of renin secretion.
• Antihypertensive agents can affect renin release, highlighting pharmacological relevance.
• Renin secretion is a biomarker and therapeutic target in cardiovascular disease.
• CRISPR models enable causal testing of genes controlling renin secretion.
What Happens During renin secretion into blood stream?
Juxtaglomerular cell activation
In simple terms: Specialized kidney cells decide when to release renin.
Renin secretion into blood stream occurs from juxtaglomerular cells, which are specialized cells located in the kidney. These cells respond to physiological signals such as changes in blood pressure and sympathetic tone, and their activation is the first step in regulated renin release. Immunocytochemical studies have localized renin within specific intrarenal compartments, confirming that juxtaglomerular cells are the principal source of circulating renin.
Sympathetic and cAMP-dependent signaling
In simple terms: Nerve signals and cAMP help trigger renin release.
Systemic beta-adrenergic stimulation and sympathetic nerve system stimulation influence the intrarenal RAS through cAMP. This signaling pathway can promote renin secretion and downstream RAS activity, linking neural control to the regulated release of renin into the bloodstream. The involvement of cAMP highlights a second-messenger mechanism that integrates systemic stress signals with juxtaglomerular cell secretion.
Local RAS and angiotensinogen availability
In simple terms: Local tissues can supply the raw material for the RAS.
Perivascular adipose tissue can locally synthesize angiotensinogen, the substrate for renin, and thereby modulate vascular function. This local angiotensinogen pool can influence the consequences of renin secretion into the blood stream, because renin activity depends on substrate availability. The existence of such local RAS components suggests that renin secretion is not only a systemic endocrine event but also interacts with paracrine tissue signals.
Release into the bloodstream
In simple terms: Renin is exported into blood to start the RAS cascade.
The regulated release of renin into the blood stream allows renin to cleave angiotensinogen and initiate the RAS cascade. This step is rate-limiting, so the amount of renin secreted directly determines the level of angiotensin II production and its downstream effects on blood pressure and fluid balance. Antihypertensive agents can alter renin release, demonstrating that this secretion step is pharmacologically accessible.
Key Genes Involved in GO:0002001 renin secretion into blood stream
The following genes and proteins are directly or indirectly involved in renin secretion into blood stream and its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| REN | Encodes renin, the enzyme secreted into the blood stream | Core gene for GO:0002001; target for KO and point-mutation studies |
| AGT | Encodes angiotensinogen, the substrate for renin | Local angiotensinogen synthesis in perivascular adipose tissue modulates RAS |
| ACE | Encodes angiotensin-converting enzyme, which generates angiotensin II | Intrarenal localization indicates compartmentalized RAS |
| AGTR1 | Encodes angiotensin II receptor type 1, mediating RAS effects | Relevant to renal fibrosis and inflammation models |
| ADRB1 | Beta-adrenergic receptor mediating sympathetic stimulation | Links sympathetic tone to cAMP and renin secretion |
| ADRB2 | Beta-adrenergic receptor involved in systemic sympathetic signaling | Potential modifier of renin secretion via cAMP |
| PRKACA | Catalytic subunit of cAMP-dependent protein kinase | Downstream effector of cAMP in renin-secreting cells |
| PRKACB | Catalytic subunit of cAMP-dependent protein kinase | Potential redundant kinase in cAMP signaling |
| GNAS | G protein alpha subunit coupled to beta-adrenergic receptors | Upstream of cAMP generation in renin secretion |
| ADCYAP1 | Neuropeptide that can modulate sympathetic tone | Indirect regulator of renin secretion via neural pathways |
| NOS1 | Neuronal nitric oxide synthase, modulates renal hemodynamics | May influence juxtaglomerular cell function |
| COX2 | Prostaglandin synthase involved in renal signaling | Inflammation-related modulation of RAS |
| NFKB1 | Transcription factor in inflammatory signaling | Links inflammation to renal RAS and fibrosis |
| TGFB1 | Profibrotic cytokine downstream of RAS | Mediates renal fibrosis in angiotensin II-infused models |
| COL1A1 | Collagen component in fibrosis | Readout of RAS-driven renal fibrosis |
| ACTA2 | Smooth muscle actin, marker of myofibroblasts | Fibrosis marker in RAS-related kidney injury |
| IL6 | Inflammatory cytokine | Inflammation marker in RAS-driven renal disease |
How Is renin secretion into blood stream Regulated?
Renin secretion into blood stream is regulated by multiple inputs. Sympathetic beta-adrenergic stimulation and cAMP signaling influence the intrarenal RAS and can promote renin release. Local angiotensinogen synthesis in perivascular adipose tissue can modulate vascular RAS and indirectly affect renin secretion. Antihypertensive agents can also alter renin release, indicating pharmacological regulation. Intrarenal compartmentalization of renin, angiotensinogen, converting enzyme and angiotensins further suggests that local tissue factors fine-tune renin secretion.
renin secretion into blood stream and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| REN | Hypertension and RAS dysregulation | Ren knockout or point-mutation models |
| AGT | Local RAS modulation in vascular tissue | Perivascular adipose tissue-specific overexpression |
| AGTR1 | Renal fibrosis and inflammation | Angiotensin II-infused mouse model |
| ADRB1 | Sympathetic regulation of renin secretion | Beta-adrenergic stimulation in cell models |
| TGFB1 | RAS-driven renal fibrosis | TGFB1 knockout or knockdown in fibrosis models |
Hypertension and cardiovascular disease
Renin secretion into blood stream is the rate-limiting step of the RAS, which controls blood pressure and vascular tone. Excessive or inappropriate renin secretion can contribute to hypertension and congestive cardiac failure. Antihypertensive agents that affect renin release are used clinically, underscoring the therapeutic relevance of this process.
Renal fibrosis and inflammation
Angiotensin II, generated downstream of renin secretion, promotes renal fibrosis and inflammation. In angiotensin II-infused mice, treatments such as rikkunshito can reduce renal fibrosis and inflammation, indicating that RAS-driven pathology is modifiable. Therefore, dysregulated renin secretion may exacerbate kidney injury through RAS activation.
Ocular and local RAS
Systemic beta-adrenergic stimulation influences the intraocular RAS through cAMP in the retinal pigment epithelium. This suggests that renin secretion-related mechanisms may also operate in local tissue RAS outside the kidney. Perivascular adipose tissue can locally synthesize angiotensinogen, further expanding the disease relevance of local RAS modulation.
From renin secretion into blood stream-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does REN loss abolish renin secretion into blood stream? | REN knockout cell or animal model |
| Does a point mutation in REN alter secretion efficiency? | REN point-mutation knock-in model |
| Can tagged REN track secretion dynamics? | Tagged REN knock-in reporter |
| Does ADRB1 overexpression enhance cAMP-driven renin release? | ADRB1 overexpression cell model |
| Does AGT overexpression in perivascular adipose tissue affect RAS? | AGT overexpression model |
| Does AGTR1 knockout reduce renal fibrosis? | AGTR1 knockout in angiotensin II-infused mice |
How to Study the renin secretion into blood stream Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunocytochemistry | Localization of renin and RAS components | Mapping intrarenal RAS compartments |
| cAMP assay | Intracellular cAMP levels | Assessing beta-adrenergic signaling in renin secretion |
| Angiotensin II infusion model | Renal fibrosis and inflammation | Testing RAS-driven kidney injury |
| Perivascular adipose tissue explants | Local angiotensinogen synthesis | Studying vascular RAS modulation |
| Antihypertensive agent testing | Renin release changes | Pharmacological regulation of renin secretion |
| Blood pressure monitoring | Systemic hemodynamic effects | Linking renin secretion to cardiovascular outcomes |
| Renin activity assay | Enzymatic activity of secreted renin | Quantifying functional renin release |
| Gene expression profiling | RAS-related gene transcription | Identifying molecular changes in disease models |
Immunocytochemistry and localization
Immunocytochemical studies have been used to localize renin, angiotensinogen, converting enzyme and angiotensins in the kidney of mouse and rat. This method reveals the spatial organization of the intrarenal RAS and helps identify juxtaglomerular cells responsible for renin secretion.
cAMP and beta-adrenergic signaling assays
Systemic beta-adrenergic stimulation and sympathetic nerve system stimulation influence the intrarenal RAS through cAMP. Measuring cAMP levels and downstream kinase activity can therefore assess signaling pathways that regulate renin secretion.
Renal fibrosis and inflammation models
Angiotensin II-infused mouse models are used to study renal fibrosis and inflammation downstream of RAS activation. These models can evaluate how altered renin secretion contributes to kidney pathology.
Perivascular adipose tissue studies
Perivascular adipose tissue can locally synthesize angiotensinogen and modulate vascular function. Experimental models that manipulate this tissue can clarify how local RAS components influence renin secretion.
How CRISPR Can Be Used to Study GO:0002001 renin secretion into blood stream
Knockout
CRISPR knockout of REN or other RAS genes can abolish or reduce renin secretion into blood stream, allowing causal testing of gene function. Knockout models of AGTR1 or TGFB1 can reveal downstream effects on renal fibrosis and inflammation.
Point Mutation
Point mutations in REN can be introduced to test how specific amino acid changes affect renin secretion efficiency and enzymatic activity. Such models help distinguish secretion defects from catalytic defects.
Knock-in
Knock-in of tagged REN or reporter alleles enables real-time tracking of renin secretion from juxtaglomerular cells. Knock-in of human REN variants can model human disease-associated mutations.
Overexpression
Overexpression of AGT in perivascular adipose tissue can increase local angiotensinogen availability and modulate vascular RAS. Overexpression of ADRB1 or other beta-adrenergic receptors can enhance cAMP signaling and renin secretion.
How EDITGENE Supports renin secretion into blood stream Research
Researchers studying renin secretion into blood stream-related genes often need to determine whether a candidate gene is causally involved in juxtaglomerular cell function, RAS activation or disease progression. EDITGENE provides CRISPR-based cell and animal models to test these hypotheses with precision.
Contact EDITGENE today to design your custom CRISPR model for renin secretion into blood stream research.
Frequently Asked Questions About renin secretion into blood stream
What is renin secretion into blood stream (GO:0002001)?
It is the regulated release of renin into the blood stream by juxtaglomerular cells, as defined by the Gene Ontology.
What genes are involved in renin secretion into blood stream?
Key genes include REN, AGT, ACE, AGTR1, ADRB1, ADRB2 and components of the cAMP signaling pathway.
How is renin secretion regulated?
It is regulated by sympathetic beta-adrenergic stimulation, cAMP signaling, local angiotensinogen availability and pharmacological agents.
Why is renin secretion important for blood pressure?
Renin is the rate-limiting enzyme of the RAS, and its secretion controls angiotensin II production, which regulates blood pressure and fluid balance.
What diseases are linked to abnormal renin secretion?
Hypertension, congestive heart failure, renal fibrosis and inflammation have been linked to RAS dysregulation.
What cell types secrete renin?
Juxtaglomerular cells in the kidney are the principal source of circulating renin.
Can CRISPR be used to study renin secretion?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models can test gene function in renin secretion.
What is the role of cAMP in renin secretion?
cAMP mediates beta-adrenergic signaling that influences the intrarenal RAS and renin release.
Does perivascular adipose tissue affect renin secretion?
Perivascular adipose tissue can locally synthesize angiotensinogen and modulate vascular RAS, indirectly influencing renin secretion.
What methods are used to study renin secretion?
Immunocytochemistry, cAMP assays, angiotensin II infusion models and renin activity assays are commonly used.
Conclusion
Renin secretion into blood stream (GO:0002001) is a tightly regulated biological process that initiates the renin-angiotensin system and controls blood pressure, fluid balance and vascular function. Dysregulation of this process contributes to hypertension, heart failure and renal fibrosis, making it a critical research area. CRISPR-based models and advanced bioinformatics are powerful tools to dissect the genetic and signaling networks governing renin secretion.
References
- 1. Cruz-López EO et al.. 2021. Perivascular Adipose Tissue in Vascular Function: Does Locally Synthesized Angiotensinogen Play a Role?. J Cardiovasc Pharmacol 78(Suppl 6):S53-S62 PMID: 34840262
- 3. Harris P. 1987. Congestive cardiac failure: central role of the arterial blood pressure.. Br Heart J 58(3):190-203 PMID: 3311096
- 5. Martins JR et al.. 2019. Systemic ß adrenergic stimulation/ sympathetic nerve system stimulation influences intraocular RAS through cAMP in the RPE.. Exp Eye Res 189:107828 PMID: 31589840
- 6. Haas E et al.. 1975. Release of antirenin to human renin by anaphylactic shock or by antihypertensive agents.. Am J Physiol 228(4):980-4 PMID: 1130530
- 7. Azushima K et al.. 2019. Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice.. Sci Rep 9(1):6201 PMID: 30996242
- 8. Taugner R et al.. 1982. The intrarenal renin-angiotensin-system. An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins in the kidney of mouse and rat.. Klin Wochenschr 60(19):1218-22 PMID: 6292570
